AAAAAA

   
Results: 1-8 |
Results: 8
INTERIM ANALYSIS OF THE INCIDENCE OF BREAST-CANCER IN THE ROYAL-MARSDEN-HOSPITAL TAMOXIFEN RANDOMIZED CHEMOPREVENTION TRIAL
Authors: POWLES T EELES R ASHLEY S EASTON D CHANG J DOWSETT M TIDY A VIGGERS J DAVEY J
Citation: T. Powles et al., INTERIM ANALYSIS OF THE INCIDENCE OF BREAST-CANCER IN THE ROYAL-MARSDEN-HOSPITAL TAMOXIFEN RANDOMIZED CHEMOPREVENTION TRIAL, Lancet, 352(9122), 1998, pp. 98-101
THE EFFECTS OF NORETHISTERONE ON ENDOMETRIAL ABNORMALITIES IDENTIFIEDBY TRANSVAGINAL ULTRASOUND SCREENING OF HEALTHY POST MENOPAUSAL WOMENON TAMOXIFEN OR PLACEBO
Authors: POWLES TJ BOURNE T ATHANASIOU S CHANG J GRUBOCK K ASHLEY S OAKES L TIDY A DAVEY J VIGGERS J HUMPHRIES S COLLINS W
Citation: Tj. Powles et al., THE EFFECTS OF NORETHISTERONE ON ENDOMETRIAL ABNORMALITIES IDENTIFIEDBY TRANSVAGINAL ULTRASOUND SCREENING OF HEALTHY POST MENOPAUSAL WOMENON TAMOXIFEN OR PLACEBO, British Journal of Cancer, 78(2), 1998, pp. 272-275
THE EFFECT OF ORAL CLODRONATE ON BONE-MINERAL DENSITY IN WOMEN WITH PRIMARY BREAST-CANCER
Authors: POWLES TJ MCCLOSKEY E PATERSON AHG ASHLEY S TIDY A KANIS J
Citation: Tj. Powles et al., THE EFFECT OF ORAL CLODRONATE ON BONE-MINERAL DENSITY IN WOMEN WITH PRIMARY BREAST-CANCER, European journal of cancer, 33, 1997, pp. 344-344
REPROGRAMMING OF TELOMERASE BY EXPRESSION OF MUTANT TELOMERASE RNA TEMPLATE IN HUMAN-CELLS LEADS TO ALTERED TELOMERES THAT CORRELATE WITH REDUCED CELL VIABILITY
Authors: MARUSIC L ANTON M TIDY A WANG P VILLEPONTEAU B BACCHETTI S
Citation: L. Marusic et al., REPROGRAMMING OF TELOMERASE BY EXPRESSION OF MUTANT TELOMERASE RNA TEMPLATE IN HUMAN-CELLS LEADS TO ALTERED TELOMERES THAT CORRELATE WITH REDUCED CELL VIABILITY, Molecular and cellular biology, 17(11), 1997, pp. 6394-6401
EFFECT OF TAMOXIFEN ON BONE-MINERAL DENSITY MEASURED BY DUAL-ENERGY X-RAY ABSORPTIOMETRY IN HEALTHY PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN
Authors: POWLES T HICKISH T KANIS JA TIDY A ASHLEY S
Citation: T. Powles et al., EFFECT OF TAMOXIFEN ON BONE-MINERAL DENSITY MEASURED BY DUAL-ENERGY X-RAY ABSORPTIOMETRY IN HEALTHY PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN, Journal of clinical oncology, 14(1), 1996, pp. 78-84
THE EFFECT OF HORMONE REPLACEMENT THERAPY AND TAMOXIFEN ON SERUM-CHOLESTEROL IN HEALTHY POSTMENOPAUSAL WOMEN
Authors: CHANG J POWLES TJ ASHLEY S GREGORY RK TIDY A
Citation: J. Chang et al., THE EFFECT OF HORMONE REPLACEMENT THERAPY AND TAMOXIFEN ON SERUM-CHOLESTEROL IN HEALTHY POSTMENOPAUSAL WOMEN, British Journal of Cancer, 74, 1996, pp. 33-33
MITOXANTRONE AND METHOTREXATE (2M), A NEW CHEMOTHERAPY REGIMEN FOR BREAST-CANCER THAT CAN BE SAFELY COMBINED WITH TAMOXIFEN
Authors: IVESON TJ POWLES TJ TIDY A ASHLEY S
Citation: Tj. Iveson et al., MITOXANTRONE AND METHOTREXATE (2M), A NEW CHEMOTHERAPY REGIMEN FOR BREAST-CANCER THAT CAN BE SAFELY COMBINED WITH TAMOXIFEN, European journal of cancer, 31A, 1995, pp. 57-57
PHASE-I STUDY OF MITOXANTRONE, METHOTREXATE AND MITOMYCIN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR (FILGRASTIM) IN PATIENTS WITH ADVANCEDBREAST-CANCER
Authors: OBRIEN MER NICOLSON M MONTES A TIDY A ASHLEY S POWLES TJ
Citation: Mer. Obrien et al., PHASE-I STUDY OF MITOXANTRONE, METHOTREXATE AND MITOMYCIN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR (FILGRASTIM) IN PATIENTS WITH ADVANCEDBREAST-CANCER, British Journal of Cancer, 70(5), 1994, pp. 980-983
Risultati: 1-8 |